ChinaBio(R) LLC Release: JOINN of China Buys Bayer AG's San Francisco-Area Campus

Published: Jan 10, 2013

by Richard Daverman, PhD

January 8, 2013 -- Joinn Laboratories, a pre-clinical CRO with facilities in Beijing and Taicang, bought the major biopharma campus in the San Francisco Bay area that formerly belonged to Bayer. Joinn, which was founded in 1995, is implementing a “go-big” strategy. It wants to offer major pharmaceutical companies the ability to work on several major projects simultaneously, minimizing the number of CRO contacts each pharma must maintain. Toward that end, Joinn is also building a 1.2 million square foot lab/office space in Taicang, in addition to its newly acquired facility in California. More details....

Stock Symbol: (Xetra: BAY)

Back to news